Home › Funds › PKO Investment Management Joint-Stock Co › GILD

PKO Investment Management Joint-Stock Co position in GILD

GILEAD SCIENCES INC · Health Care

PKO Investment Management Joint-Stock Co reported holding 49,000 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$7.3M, representing 0.50% of its reported portfolio and ranking #44 among its reported holdings. PKO Investment Management Joint-Stock Co has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)49.00K sh
Reported value held$7.30M
Portfolio Weight0.50%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PKO Investment Management Joint-Stock Co's GILD position evolved

PKO Investment Management Joint-Stock Co first disclosed a stake in GILD in Q3 2023 at 10,000 shares (US$749K). The position peaked in Q2 2026 at 58,500 shares, worth US$7.4M. Across 13 filings, PKO Investment Management Joint-Stock Co increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 49,000 shares valued at US$7.3M — a reduction of -9,500 shares quarter over quarter.. Notable position changes include a 100% increase in Q4 2024 (shares rose 21% over the following quarter), a 200% increase in Q2 2025 (shares were roughly flat over the following quarter), a 322% increase in Q3 2025 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.00K $749.40K New
Q4 2023 5.00K $405.05K Reduce
Q1 2024 10.00K $736.08K Add
Q2 2024 6.00K $411.66K Reduce
Q3 2024 3.00K $251.52K Reduce
Q4 2024 6.00K $554.22K Add
Q1 2025 3.00K $336.15K Reduce
Q2 2025 9.00K $997.83K Add
Q3 2025 38.00K $4.22M Add
Q4 2025 39.00K $4.79M Add
Q1 2026 49.00K $6.83M Add
Q2 2026 58.50K $7.39M Add
Q3 2026 49.00K $7.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has PKO Investment Management Joint-Stock Co held GILD?

PKO Investment Management Joint-Stock Co has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PKO Investment Management Joint-Stock Co's current position in GILD?

As of Q3 2026, PKO Investment Management Joint-Stock Co holds 49.00K shares of GILD (GILEAD SCIENCES INC), valued at $7.30M, representing 0.50% of its reported portfolio and ranking #44.

Has PKO Investment Management Joint-Stock Co been buying or selling GILD?

In the latest 13F filing (Q3 2026), PKO Investment Management Joint-Stock Co reduced its position in GILD. The position peaked in Q2 2026 at 58.50K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.